Akili, Inc.
AKLI
$0.00
Change (1 day)
$1.25
Year High
$0.19
Year Low
Categories
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.
Revenue of Akili, Inc. (AKLI)
Revenue in 2023 (TTM): $1.68 M
According to Akili, Inc.'s latest financial reports the company's current revenue (TTM) is $1.68 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Akili, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $1.68 M | $859 K | $-60,143,000 | $-59,493,000 | $-59,493,000 |
| 2022 | $323 K | $-118,000 | $-88,887,000 | $-7,945,000 | $-7,964,000 |
| 2021 | $538 K | $183 K | $-60,440,000 | $-61,348,000 | $-61,830,000 |
| 2020 | $3.94 M | $3.52 M | $-25,012,000 | $-25,645,000 | $-25,646,000 |
| 2019 | $19.99 M | $18.64 M | $-20,213,000 | $-20,621,000 | $-20,634,000 |